United States · FDA National Drug Code directory

SPIRONOLACTONE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-1627_a6caa2b8-b27e-47eb-9db8-ccfa8e8b6a8b
Product NDC
72162-1627
Form
TABLET, FILM COATED
Composition / generic term
SPIRONOLACTONE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
19860723
Source listing expiry
20271231

Source-listed ingredients

  • SPIRONOLACTONE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (72162-1627-1) · 72162-1627-1
  • 100 TABLET, FILM COATED in 1 BOTTLE (72162-1627-2) · 72162-1627-2
  • 30 TABLET, FILM COATED in 1 BOTTLE (72162-1627-3) · 72162-1627-3
  • 60 TABLET, FILM COATED in 1 BOTTLE (72162-1627-4) · 72162-1627-4
  • 500 TABLET, FILM COATED in 1 BOTTLE (72162-1627-5) · 72162-1627-5
  • 30 TABLET, FILM COATED in 1 BOTTLE (72162-1627-7) · 72162-1627-7

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
SPIRONOLACTONE — United States | Molindra Medicines